A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506)

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 9, 1997, Pages 1662-1666

  Cattaneo, Marco ^a,d   Tsai, Michael Y ^c   Bucciarelli, Paolo ^a   Taioli, Emanuela ^a,b   Zighetti, Maddalena L ^a   Bignell, Michelle ^c   Mannucci, Pier Mannuccio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIV OF MINNESOTA HOSP AND CLINIC   (United States)

^d Hemophilia and Throms Center   (Italy)

Author keywords

Deep vein thrombosis; Homocysteine; Hyperhomocysteinemia; Methylenetetrahydrofolate reductase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 5; HOMOCYSTEINE; PROTEIN C; PROTEIN S;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; GENE MUTATION; HOMOZYGOSITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030760946     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.9.1662     Document Type: Article

References (27)

1. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood. 1996;87: 3531-3544.
2. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C deficient families. Blood. 1994;84:1031.
3. Zöller B, Berntsdotter A, Garcia de Frutos P, Dahlbäck B. Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein S. Blood. 1995;85:3518-3523.
4. Radtke K-P, Lane DA, Greengard JS, Ehrenforth S, Griffin JH, Scharrer I. Combined hereditary APC resistance and ATIII type II deficiency associated with venous thrombosis. Thromb Haemost. 1995:73:1377. Abstract.
5. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA. 1993;90: 1004-1009.
6. Bertina RM, Koeleman BP, Koster T, Rosendal FR, Dirven RJ, de Ronde H, Van der Velde PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
7. Dahlbäck B. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood. 1995;85:607-614.
8. Falcon C, Cattaneo M, Panzeri D, Martinelli I, Mannucci PM. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb. 1994;14:1080-1083.
9. Fermo I, Viganò D'Angelo S, Paroni R, Mazzola G, Calori G, D'Angelo A. Prevalence of moderate hyperhomocysteinemia in patients with early-onset venous and arterial occlusive disease. Ann Intern Med. 1995;123:747-753.
10. den Heijer M, Blom HJ, Gerrits WBJ, Rosendaal FR, Haak HL, Wijermans PW, Bos GMJ. Is hyperhomocysteinemia a risk factor for recurrent venous thrombosis? Lancet. 1995;345:882-885.
11. den Heijer M, Koster T, Blom HJ, Bos GMJ, Briët E, Reitsma PH, Vandenbrouke JP, Rosendaal FR. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334:759-762.
12. McCuIly KS. Homocysteine and vascular disease. Nat Med. 1996;2: 386-389.
13. Rees MM, Rodgers GM. Homocysteinemia: association of a metabolic disorder with vascular disease and thrombosis. Thromb Res. 1993:71:337-359.
14. Kang S-S, Zhou J, Wong PWK, Kowalisyn J, Strokosh G. Intermediate homocysteinemia: a thermolabile variant of methylenetet-rahydrofolate reductase. Am J Hum Genet. 1988;43:414-421.
15. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvcl LP, Rozen R. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
16. Kluijtmans LAJ, van den Heauvel LPWJ, Boers GHJ, Frosst P, Stevens EMB, van Oost BA, den Heijer M, Trijbels FJM, Rozen R, Blom HJ. Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet. 1996;58:35-41.
17. Frezzato M, Tosetto A, Rodeghiero F. Validation of a questionnaire for the diagnosis of venous thromboembolism. Br J Haematol. 1994;87:79-84.
18. de Ronde H, Bertina RM. Laboratory diagnosis of APC-resistance: a critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost. 1994;72:880-886.
19. Ubbink JB, Vermaakl WJH, Bissburt S. Rapid high performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr. 1991;565:441-449.
20. Faioni EM, Franchi F, Asti D, Sacchi E, Bernardi F, Mannucci PM. Resistance to activated protein C in nine thrombophilic families: interference with a protein S assay. Thromb Haemost. 1993;70:1067-1071.
21. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost. 1995;74:1185-1190.
22. Triplett DA. Antiphospholipid-protein antibodies: laboratory detection and clinical relevance. Thromb Res. 1995;78:1-31.
23. Wilcken DE, Wang XL, Sim AS, McCredie RM. Distribution in healthy and coronary populations of the methylenetetrahydrofolate reductase (MTHFR) C677T mutation. Arterioscler Thromb Vasc Biol. 1996;16:878-882.
24. Mannucci PM, Duca F, Peyvandi F, Tagliabue L, Merati G, Martinelli I, Cattaneo M. Frequency of factor V Arg506 Gin in Italians. Thromb Haemost. 1996;75:694.
25. Jaques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R. Relation between folate Status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9.
26. Miller JW, Nadeau MR, Smith D, Selhub J. Vitamin B6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr. 1994;59:1033-1039.
27. Mandel H, Brenner B, Berant M, Rosenberg N, Lanir N, Jakobs C, Fowler B, Seligson U. Coexistence of hereditary homocystinuria and factor V Leiden: effect on thrombosis. N Engl J Med. 1996;334: 763-768.